[HTML][HTML] A randomized trial of genotype-guided dosing of warfarin

…, G Burnside, N Eriksson, AL Jorgensen… - … England Journal of …, 2013 - Mass Medical Soc
Background The level of anticoagulation in response to a fixed-dose regimen of warfarin is
difficult to predict during the initiation of therapy. We prospectively compared the effect of …

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

…, N Liu, AHB Wu, BF Gage, A Jorgensen… - Blood, The Journal …, 2010 - ashpublications.org
Warfarin-dosing algorithms incorporating CYP2C9 and VKORC1 −1639G>A improve dose
prediction compared with algorithms based solely on clinical and demographic factors. …

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

A Alfirevic, AL Jorgensen, PR Williamson… - 2006 - Future Medicine
Background: A strong pharmacogenetic association has been reported in Chinese patients
between human leukocyte antigen (HLA)-B*1502 and carbamazepine (CBZ)-induced …

[HTML][HTML] Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues

GL Hickey, P Philipson, A Jorgensen… - BMC medical research …, 2016 - Springer
Background Available methods for the joint modelling of longitudinal and time-to-event
outcomes have typically only allowed for a single longitudinal outcome and a solitary event time. …

[HTML][HTML] Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis

AL Jorgensen, RJ FitzGerald, J Oyee, M Pirmohamed… - 2012 - journals.plos.org
Background Warfarin is a highly effective anticoagulant however its effectiveness relies on
maintaining INR in therapeutic range. Finding the correct dose is difficult due to large inter-…

[HTML][HTML] Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study

…, A Hingorani, N Hukerikar, A Jorgensen… - The Lancet Digital …, 2023 - thelancet.com
Background Globally, there is a paucity of multimorbidity and comorbidity data, especially
for minority ethnic groups and younger people. We estimated the frequency of common …

Methodologies for social life cycle assessment

A Jørgensen, A Le Bocq, L Nazarkina… - The international journal …, 2008 - Springer
Goal, Scope and Background In recent years several different approaches towards Social
Life Cycle Assessment (SLCA) have been developed. The purpose of this review is to …

[HTML][HTML] Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies

…, J Cooper, SHL Thomas, AL Jorgensen… - The Lancet …, 2018 - thelancet.com
Background Paracetamol overdose is common but patient stratification is suboptimal. We
investigated the usefulness of new biomarkers that have either enhanced liver specificity (…

Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population

DF Carr, M Chaponda, AL Jorgensen… - Clinical Infectious …, 2013 - academic.oup.com
Background. The nonnucleoside reverse transcriptase inhibitor nevirapine is the cornerstone
of treatment for human immunodeficiency virus (HIV) in many sub-Saharan African …

[HTML][HTML] Biomarker-guided adaptive trial designs in phase II and phase III: a methodological review

M Antoniou, AL Jorgensen, R Kolamunnage-Dona - PloS one, 2016 - journals.plos.org
Background Personalized medicine is a growing area of research which aims to tailor the
treatment given to a patient according to one or more personal characteristics. These …